Suppr超能文献

中性粒细胞与淋巴细胞比值和淋巴结密度能否作为根治性膀胱切除术患者的预后因素?

Can neutrophil-lymphocyte ratio and lymph node density be used as prognostic factors in patients undergoing radical cystectomy?

作者信息

Demirtaş Abdullah, Sabur Volkan, Akınsal Emre Can, Demirci Deniz, Ekmekcioglu Oguz, Gulmez Ibrahim, Tatlisen Atila

机构信息

Department of Urology, Erciyes University Medical Faculty, 38039 Kayseri, Turkey.

出版信息

ScientificWorldJournal. 2013 Mar 31;2013:703579. doi: 10.1155/2013/703579. Print 2013.

Abstract

OBJECTIVE

To assessment the role of preoperative neutrophil-lymphocyte ratio and postoperative lymph node density in predicting prognosis in patients undergoing radical cystectomy for bladder cancer.

MATERIAL AND METHODS

Preoperatively, neutrophil and lymphocyte counts as well as neutrophil-lymphocyte ratios were recorded in 201 patients who underwent radical cystectomy for bladder cancer. Patients with an infection were excluded. Based on the pathology reports, the number of positive lymph nodes was divided by the total number of lymph nodes to calculate lymph node density.

RESULTS

The mean follow-up duration was 37.22 ± 35.922 months in patients without lymph node involvement and 27.75 ± 31.501 months in those with lymph node involvement (P = 0.015). Median lymph node density was 17% (4-80) in patients with lymph node involvement. There was no difference according to lymph node density lower than 17% and greater than 17% (P = 0.336). There was no significant difference between patients with an NLR below or above 2.5 in terms of overall survival (P = 0.702). Pathological T stage was associated with survival (P = 0.004).

CONCLUSION

In patients undergoing RC for bladder cancer, lymph node density and preoperative NLR were not found to be independent predictors of prognosis.

摘要

目的

评估术前中性粒细胞与淋巴细胞比值及术后淋巴结密度在预测膀胱癌根治性膀胱切除患者预后中的作用。

材料与方法

术前,记录201例行膀胱癌根治性膀胱切除患者的中性粒细胞和淋巴细胞计数以及中性粒细胞与淋巴细胞比值。排除有感染的患者。根据病理报告,将阳性淋巴结数量除以淋巴结总数以计算淋巴结密度。

结果

无淋巴结转移患者的平均随访时间为37.22±35.922个月,有淋巴结转移患者为27.75±31.501个月(P = 0.015)。有淋巴结转移患者的中位淋巴结密度为17%(4 - 80)。淋巴结密度低于17%和高于17%的患者之间无差异(P = 0.336)。NLR低于或高于2.5的患者在总生存期方面无显著差异(P = 0.702)。病理T分期与生存率相关(P = 0.004)。

结论

在接受膀胱癌根治性膀胱切除术的患者中,未发现淋巴结密度和术前NLR是预后的独立预测因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e781/3628500/47f4ee0f0d95/TSWJ2013-703579.001.jpg

相似文献

1
Can neutrophil-lymphocyte ratio and lymph node density be used as prognostic factors in patients undergoing radical cystectomy?
ScientificWorldJournal. 2013 Mar 31;2013:703579. doi: 10.1155/2013/703579. Print 2013.
10
The prognostic value of routine preoperative blood parameters in muscle-invasive bladder cancer.
BMC Urol. 2020 Mar 19;20(1):31. doi: 10.1186/s12894-020-00602-9.

引用本文的文献

1
Clinical Value of Postoperative Neutrophil-to-Lymphocyte Ratio Change as a Detection Marker of Bladder Cancer Recurrence.
Cancer Manag Res. 2021 Jan 29;13:849-860. doi: 10.2147/CMAR.S289986. eCollection 2021.

本文引用的文献

1
4
Cancer statistics, 2010.
CA Cancer J Clin. 2010 Sep-Oct;60(5):277-300. doi: 10.3322/caac.20073. Epub 2010 Jul 7.
5
The present and future burden of urinary bladder cancer in the world.
World J Urol. 2009 Jun;27(3):289-93. doi: 10.1007/s00345-009-0383-3. Epub 2009 Feb 15.
6
Neutrophil/lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer.
J Thorac Cardiovasc Surg. 2009 Feb;137(2):425-8. doi: 10.1016/j.jtcvs.2008.05.046. Epub 2008 Aug 29.
8
Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment.
Cancer Immunol Immunother. 2009 Jan;58(1):15-23. doi: 10.1007/s00262-008-0516-3. Epub 2008 Apr 15.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验